While these results suggest that AR-FL is the most predominant transcript overall, when we analyzed the data on a per patient-basis we observed inter- and intra-patient heterogeneity in the proportion of single CTCs expressing each transcript, in agreement with a previous report on single CTC RNA-Seq from prostate cancer patients21. This evidence concerns the gene AR and prostate cancer.